Notes in 01_Antiphospholipid Syndrome (APLS)

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	{{c1::Antiphospholipid Syndrome (APLS)}} is {{c2::an acquired thrombophilic conditions that is characterized by an autoimmune background producing ant…
Published	02/10/2024	Antiphospholipid Syndrome (APLS) is present in {{c1::15}}% of women who present with recurrent miscarriages especially in the second and third trimest…
Published	02/10/2024	Presentation of {{c2::Antiphospholipid Syndrome (APLS)}} {{c1::Recurrent miscarriages}} {{c1::Arterial and venous thrombosis}} {{c1::Livedo reticulari…
Published	02/10/2024	Testing for Antiphospholipid Syndrome (APLS) should be done in women with ≥{{c1::3}} recurrent miscarriages
Published	02/10/2024	Investigations of Antiphospholipid Syndrome (APLS) {{c1::Full Blood Count (anaemia, normal platelets or thrombocytopenia)}} {{c1::Coagulation Screen (…
Published	02/10/2024	Antibodies in {{c2::Antiphospholipid Syndrome (APLS)}} include {{c1::Anticardiolipin}} and {{c1::Anti-beta-2-glycoprotein-1}} antibodies
Published	02/10/2024	Management of Antiphospholipid Syndrome (APLS)After venous event: {{c1::Commence Lifelong Warfarin (INR 2-3) and consider a higher INR if its inadequa…
Published	02/10/2024	Management of Antiphospholipid Syndrome (APLS)History of Recurrent Miscarriage: {{c1::Active Monitoring along with Low Molecular Weight Heparin (LMWH)…
Published	02/10/2024	Management of Antiphospholipid Syndrome (APLS)History of Systemic Lupus and APLS: {{c1::Hydroxychloroquine (thromboprotective)}}
Status	Last Update	Fields